HeartMate III is a next-generation continuous flow left ventricular assist device (:LVAD) based on fully magnetically levitated technology. This technology helps in reducing adverse event rates ...

PLEASANTON, Calif., /PRNewswire/ -- Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that its CE ...

HeartMate III is the next-generation continuous flow left ventricular assist device (:LVAD). It is based on fully magnetically levitated technology in order to reduce adverse event rates through ...

Manufacturer and marketer of medical devices used for mechanical circulatory support, Thoratec Corp.THOR, recently announced that the first HeartMate III implant has been conducted via ...

Abbott has issued a recall for select HeartMate mobile power units used with its HeartMate3 and HeartMate III left-ventricular assist systems due to risk of sudden power loss that could lead to ...

Sharp Memorial Hospital has become the first hospital on the West Coast — and only the sixth in the country — to implant an investigational mechanical heart pump as part of a nationwide clinical trial ...

A surgical team in Toronto has successfully implanted a novel mechanical device, the HeartMate IIITM, into a patient with advanced heart failure. This is the first time this procedure has been ...

Thoratec shed almost one-third of its value after reporting abysmal second quarter earnings. The advanced heart failure device company attributed most of the miss to a New England Journal of Medicine ...

Thoratec Corp.THOR recently announced the start of patient enrollment in the SHIELD II U.S. clinical trial, which aims at exploring the use of HeartMate PHP in patients undergoing high-risk ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The majority of ...

PLEASANTON, Calif., June 27, 2014 /PRNewswire/ --Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing ...